Delivery Order SPE2DB22D2211-SPE2DB25FSFGK
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,667.54 for 10,000 units of chorionic gonadotropin (a hormone treatment product) on June 4, 2025, with completion scheduled for June 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,985.23 delivery order to AmerisourceBergen Drug Corp for 10,000 units of chorionic gonadotropin, a hormone-based pharmaceutical product commonly used in fertility treatments and medical therapies. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price procurement under a competitively awarded arrangement with no set-aside designation. Performance of this delivery order is based in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 10,000 units of chorionic gonad with a ceiling value of $3,692.80. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed price terms, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.42 to AmerisourceBergen Drug Corp for 10,000-unit vials of Pregnyl, a human chorionic gonadotropin medication. The contract, awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- This federal contract award, valued at $5,134.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 10,000 units of chorionic gonad, a medical product. The contract is not set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,880.53, is for the delivery of 10,000 units of Chorionic Gonad, a medical product. The contract has a completion date of December 4, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in the distribution of...
- The Defense Logistics Agency awarded a $2,418.00 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Pregnyl 10,000 unit vials, with an ultimate completion date of June 2, 2025. This non-set-aside, firm fixed price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,753.52 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,199.06 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FEGU5) is for the procurement of 10,000 units of CHORIONIC GONAD, with a completion date of April 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...